Sinus Sufferers Can Now Breathe Easier

Over 30 million Americans suffer from sinusitis. It is among the most common diagnoses for patients complaining of coughing, sinus pressure, congestion, postnasal drainage and headaches. Often, patients misdiagnose themselves as simply suffering from seasonal allergies. While medications and steroids can provide relief, for many, these methods do not solve the problem entirely and surgery is required.

A new treatment for sinus sufferers:

A new treatment utilized by Dr. Oliver Jenkins and Dr. Christopher Perry of Toledo Clinic ENT is a dissolvable sinus stent (PROPEL®) that is placed into the sinuses during surgery. Just as coronary drug-eluting stents release medications into clogged arteries, the lightweight PROPEL® Stent holds open the sinus after surgery to steadily deliver low-dose anti-inflammatory medication to the healing sinus tissue. Now with the advent of the PROPEL® Stent, Dr. Jenkins and Dr. Perry have found patient recovery is quicker and their transition back to daily living has been advanced significantly.

How it works:

The PROPEL® Stent is carefully placed by an experienced Ear, Nose and Throat physician into the sinus cavity at the end of surgery. The stent remains there for a period of weeks, utilizing a spring like mechanism to open up the sinus passageway. At the same time, it provides anti-inflammatory therapy, which helps to reduce scarring and the need for oral steroids in the postoperative period. Best of all, after a few weeks the stent dissolves on its own, and no removal is necessary, making postoperative care easier on patients. “Propel has become an invaluable tool in my ENT toolbox. Propel has been great for our patients by reducing post operative pain, bleeding, recovery time and need for revision surgery,” stated Dr. Perry.

Clinical Data:

Minimally invasive sinus surgery with PROPEL® offers promising improvement for those who have experienced nasal and sinus blockage resulting from chronic sinusitis.  The outcomes associated with this new technology are highly encouraging. The stent has been studied in three prospective clinical trials conducted in the United States, and was awarded the American Rhinologic Society’s prestigious award for top-notch use of clinical science.

Conclusion:

When a patient’s chronic sinusitis does not respond to medications, surgery to enlarge the opening to drain the sinuses may provide the best option. The PROPEL® drug releasing stent offers a new weapon in the fight against chronic sinusitis, backed by clinical data and positive patient post-surgical outcomes.

About Toledo Clinic ENT

Many cases of sinusitis are acute; however, if the condition occurs frequently or lasts three months or more, you may have chronic sinusitis. See Dr. Jenkins and Dr. Perry at the Toledo Clinic ENT Sinus Center of Excellence, 5800 Park Center Court, Suite C, Toledo, 419-724-8368 or learn more about their practice and the PROPEL implant at: http://toledoclinicent.com/sinuses/propel-implant/